Journal
ACS NANO
Volume 14, Issue 8, Pages 9613-9625Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsnano.0c00082
Keywords
up-/downconversion; copper/manganese silicate; tumor microenvironment; chemodynamic/photodynamic therapy; bioimaging
Categories
Funding
- National Natural Science Foundation of China [NSFC 51602072, 51772059, 51720105015, 51929201]
- 111 Project [B20088]
- Heilongjiang Touyan Innovation Team Program (Tree Genetics and Breeding Innovation Team)
- Science and Technology Cooperation Project between Chinese and Australian [2017YFE0132300]
- Natural Science Foundation of Heilongjiang Province [YQ2019E016]
- Postdoctoral Scientific Research Developmental Fund [LBH-Q18034]
- Fundamental Research Funds for the Central Universities
Ask authors/readers for more resources
Reactive oxygen species (ROS)-based therapeutic modalities including chemodynamic therapy (CDT) and photodynamic therapy (PDT) hold great promise for conquering malignant tumors. However, these two methods tend to be restricted by the overexpressed glutathione (GSH) and hypoxia in the tumor microenvironment (TME). Here, we develop biodegradable copper/manganese silicate nanosphere (CMSN)coated lanthanide-doped nanoparticles (LDNPs) for trimodal imaging-guided CDT/PDT synergistic therapy. The tridoped Yb3+/Er3+/Tm(3+ )in the ultrasmall core and the optimal Yb3+/Ce3+ doping in the shell enable the ultrabright dual-mode upconversion (UC) and downconversion (DC) emissions of LDNPs under near-infrared (NIR) laser excitation. The luminescence in the second near-infrared (NIR-II, 1000-1700 nm) window offers deep-tissue penetration, high spatial resolution, and reduced autofluorescence when used for optical imaging. Significantly, the CMSNs are capable of relieving the hypoxic TME through decomposing H2O2 to produce O-2, which can react with the sample to generate O-1(2) upon excitation of UC photons (PDT). The GSH-triggered degradation of CMSNs results in the release of Fenton-like Mn2+ and Cu+ ions for (OH)-O-center dot generation (CDT); simultaneously, the released Mn2+ ions couple with NIR-II luminescence imaging, computed tomography (CT) imaging, and magnetic resonance (MR) imaging of LDNPs, performing a TME-amplified trimodal effect. In such a nanomedicine, the TME modulation, bimetallic silicate photosensitizer, Fenton-like nanocatalyst, and NIR-II/MR/CT contrast agent were achieved one for all, thereby realizing highly efficient tumor theranostics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available